Skip to main content
Glama

Fas

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "drug"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly, idempotent, openWorld, and non-destructive. The description adds substantial behavior beyond annotations: graceful degradation of LEI/FIGI enrichment, explicit `unresolved` fields, ambiguity handling via `figi_candidates`, and the internal cascade replacing multiple manual lookups.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but densely informative, starting with user-phrase examples before moving to supported types and edge cases. Every clause contributes operational guidance, though the length pushes the limit of front-loaded clarity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with two parameters, no output schema, but substantial hidden behavior, the description covers input variants, ambiguity resolution, enrichment failure, and internal multi-endpoint behavior. An agent has enough information to decide when to call it and how to interpret unresolved or candidate results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds critical semantics beyond the schema: accepted input forms include ISIN in addition to ticker/CIK/name, drug values accept both brand and generic names, and the value parameter must be the entity name only, with a concrete bond-issuer caveat. This materially improves correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly names the action ('resolve a user-spoken NAME to the canonical/official identifiers other tools require as input') and enumerates common queries. It does not explicitly differentiate from the sibling entity_profile tool, but the identity-to-ID focus is distinct.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly states 'Use FIRST whenever you have a name but need an ID' and enumerates supported types with concrete examples. It also gives boundary guidance, such as when a name matches multiple instruments it asserts nothing and returns figi_candidates.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Fas toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation4/5

Most tools have clearly distinct purposes (e.g., ask_pipeworx vs. deep_research vs. validate_claim). However, a few pairs like ask_pipeworx_beta vs. ask_pipeworx and validate_claim vs. ask_pipeworx_grounded have overlapping roles, even though descriptions do differentiate them.

Naming Consistency4/5

All tool names use snake_case consistently, and many follow a verb_noun pattern (ask_pipeworx, compare_entities, subscribe). Some exceptions like entity_profile, recent_alerts, and pipeworx_trending break the strict verb_noun pattern but remain readable and stylistically uniform.

Tool Count3/5

With 35 tools, this is above the typical 'well-scoped' range and exceeds the 25-tool threshold for heavy servers. However, the server covers a very broad domain (financial data, prediction markets, agriculture, AI visibility, memory, subscriptions), which partially justifies the count, but it still feels bloated.

Completeness4/5

The tool surface covers all major workflows: data querying (ask_pipeworx, deep_research), entity resolution and comparison, prediction-market analysis, agricultural data (FAS tools), memory (remember/recall/forget), and subscription management (subscribe/unsubscribe/list). The only minor gap is lack of direct write/update operations for external data, but that's not expected for a read-heavy platform.

Resources